Lead sponsor
Sonexa Therapeutics, Inc.
2 Alzheimer’s disease and related dementias trials led. Source: ClinicalTrials.gov, as of July 21, 2026.
2
Trials led
0
Ongoing
378
Total enrollment
29
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 2
2
Trials by status
Completed
2
Trials led
TrialEligibility highlightPhaseStatusEnrollment
Preliminary Efficacy and Safety Study of ST101 Plus Aricept in Alzheimer's DiseaseAlzheimer's diseasePh 2Completed210
Preliminary Efficacy and Safety Study of ST101 in Alzheimer's Diseasemild-to-moderate ADPh 2Completed168